Drug class
Ultra-long-acting beta-2 adrenergic receptor agonist (LABA); bronchodilator
Mechanism of action
Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cyclic AMP and producing prolonged bronchodilation.
General use cases
- Long-term maintenance bronchodilator treatment of airflow obstruction in adults with chronic obstructive pulmonary disease (COPD); not indicated for relief of acute bronchospasm or as asthma monotherapy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
